SCHEMBL2501720

SCHEMBL2501720

O=C1c2nc3ccccc3nc2C=CC1O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.38
▸ ALDH1A1 P00352 5/20 0.38
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ NPC1 O15118 4/20 0.38
▸ RAB9A P51151 4/20 0.38
▸ AHR P35869 1/20 0.38
▸ MEN1 O00255 4/20 0.33
▸ KMT2A Q03164 4/20 0.33
▸ BCHE P06276 1/20 0.32
▸ ACHE P22303 1/20 0.32
▸ KDM4E B2RXH2 5/20 0.32
▸ HSD17B10 Q99714 2/20 0.32
▸ TP53 P04637 2/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ TOP2A P11388 1/20 0.31
▸ TOP2B Q02880 1/20 0.31
▸ L3MBTL1 Q9Y468 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10983158 0.79 NPC1 (0.38) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL31450545 0.79 MAPT (0.38) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL2928380 0.79 MAPT (0.38) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL387792 0.79 MAPT (0.38) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL27592760 0.79 MAPT (0.38) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL6889912 0.77 MAPT (0.36) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
Sulfuric Acid SCHEMBL6839880 0.76 RAB9A (0.37) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL6669049 0.76 MAPT (0.35) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL652529 0.76 MAPT (0.39) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL28361348 0.76 ALDH1A1 (0.37) MAPTALDH1A1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115444775-A Stable composition suitable for cosmetics and skin care product thereof 广州精创舞台设备科技有限公司 2022-12-09 — — CN claimed
CN-111544317-B Anti-aging composition cationic nano-liposome and preparation method and application thereof 珀莱雅化妆品股份有限公司 2022-01-14 — — CN disclosed
CN-111544317-A Anti-aging composition cationic nano-liposome and preparation method and application thereof 珀莱雅化妆品股份有限公司 2020-08-18 — — CN disclosed
US-8637658-B2 Non-fluorescent quencher compounds and biomolecular assays APPLIED BIOSYSTEMS, LLC (US) 2014-01-28 — — US disclosed
US-20130123475-A1 Non-Fluorescent Quencher Compounds and Biomolecular Assays Life Technologies Corporation (US) 2013-05-16 — — US disclosed
US-20120220751-A1 Non-Fluorescent Quencher Compounds and Biomolecular Assays Life Technologies Corporation (US) 2012-08-30 — — US disclosed
US-20110245462-A1 Non-Fluorescent Quencher Compounds and Biomolecular Assays Life Technologies Corporation (US) 2011-10-06 — — US disclosed
US-20090105452-A1 NON-FLUORESCENT QUENCHER COMPOUNDS AND BIOMOLECULAR ASSAYS APPLERA CORPORATION (US) 2009-04-23 — — US disclosed
US-20050164225-A1 Non-fluorescent quencher compounds and biomolecular assays APPLIED BIOSYSTEMS, LLC 2005-07-28 — — US disclosed
US-20040005607-A1 Non-fluorescent quencher compounds and biomolecular assays APPLIED BIOSYSTEMS, LLC 2004-01-08 — — US disclosed
US-20030082547-A1 Non-fluorescent quencher compounds and biomolecular assays APPLIED BIOSYSTEMS, LLC 2003-05-01 — — US disclosed
WO-2003019145-A2 NON-FLUORESCENT QUENCHER COMPOUNDS AND BIOMOLECULAR ASSAYS APPLERA CORPORATION (US) 2003-03-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050164225-A1 Non-fluorescent quencher compounds and biomolecular assays DNTT, PNP, NT5C2 MAPT 4274/4885ALDH1A1 3999/4885SMN1; SMN2 3631/4885
US-20130123475-A1 Non-Fluorescent Quencher Compounds and Biomolecular Assays DNTT, PNP, NT5C2 MAPT 4230/4885ALDH1A1 3969/4885SMN1; SMN2 3606/4885
US-20030082547-A1 Non-fluorescent quencher compounds and biomolecular assays DNTT, PNP, NT5C2 MAPT 4380/4885ALDH1A1 3285/4885SMN1; SMN2 3436/4885
US-20090105452-A1 NON-FLUORESCENT QUENCHER COMPOUNDS AND BIOMOLECULAR ASSAYS DNTT, PNP, NT5C2 MAPT 4230/4885ALDH1A1 3969/4885SMN1; SMN2 3606/4885
US-20040005607-A1 Non-fluorescent quencher compounds and biomolecular assays DNTT, PNP, NT5C2 MAPT 4380/4885ALDH1A1 3285/4885SMN1; SMN2 3436/4885
US-20110245462-A1 Non-Fluorescent Quencher Compounds and Biomolecular Assays DNTT, PNP, NT5C2 MAPT 4230/4885ALDH1A1 3969/4885SMN1; SMN2 3606/4885
US-20120220751-A1 Non-Fluorescent Quencher Compounds and Biomolecular Assays DNTT, PNP, NT5C2 MAPT 4230/4885ALDH1A1 3969/4885SMN1; SMN2 3606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback